Friday, June 23, 2006
Good News On The Way?
Reuters:
U.S. health officials on Friday approved the use of a new HIV drug, made by Johnson & Johnson, in combination with related therapies to help treat patients who do not first improve with other treatment.Given the 25th anniversary of the disease has just passed, and there are around 40 million people worldwide afflicted with it, any news of possibly combating the disease with new and promising methods is welcome.
The drug, Prezista, is a protease inhibitor designed to treat resistant strains of HIV, the virus that causes AIDS.
